A Rare Case of Systemic Sclerosis with Topo I Positivity and Anti-Topoisomerase I (Scl-70) Antibody Negativity

Patients with systemic sclerosis who are anti-Scl-70 antibody negative but Topo I pattern positive may present different clinical manifestations and prognoses, requiring a comprehensive assessment that integrates clinical presentation, laboratory tests, and potential disease progression.

Authors

K Xie
Honggang Sun (ORCID: https://orcid.org/0000-0001-7400-6518)
Liqin He

Publication Details

Journal: Clinical Laboratory
Published: 2025-01-01
DOI: https://doi.org/10.7754/clin.lab.2024.241124
Primary Topic: Cytokine Signaling Pathways and Interactions
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Rare Case of Systemic Sclerosis with Topo I Positivity and Anti-Topoisomerase I (Scl-70) Antibody Negativity

K Xie, Honggang Sun, Liqin He

Jan 1, 2025

Clinical Laboratory

Cytokine Signaling Pathways and Interactions

article

A Rare Case of Systemic Sclerosis with Topo I Positivity and Anti-Topoisomerase I (Scl-70) Antibody Negativity

K Xie, Honggang Sun, Liqin He

January 1, 2025article en

Abstract

Clinical LaboratoryVol. 71(05/2025)

Openalex Percentile: Top 83%

Cytokine Signaling Pathways and Interactions

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.